MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

Historical Holders from Q1 2022 to Q1 2025

Symbol
MLTX on Nasdaq
CUSIP
61559X104
Type / Class
Equity / COMMON STOCK
Shares outstanding
63.1M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
63.2M
Holdings value
$3.42B
% of all portfolios
0.007%
Grand Portfolio weight change
+0%
Number of holders
117
Number of buys
65
Number of sells
-44
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 10% $246M 6.31M FMR LLC Dec 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/ 5.3% $131M 3.34M T. Rowe Price Associates, Inc. Dec 31, 2024

Institutional Holders of MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 186K $7.26M +$864K $39.07 3
2024 Q4 63.2M $3.42B +$68.4M $54.15 117
2024 Q3 62.1M $3.13B +$81M $50.42 111
2024 Q2 60.7M $2.67B +$45.2M $43.97 111
2024 Q1 59.3M $2.98B -$5.58M $50.23 118
2023 Q4 58.4M $3.53B +$98.9M $60.39 124
2023 Q3 56.3M $3.21B +$43.1M $57.00 118
2023 Q2 56.1M $2.86B +$861M $51.00 82
2023 Q1 39.4M $843M +$59.3M $21.39 43
2022 Q4 37.7M $396M +$8.23M $10.50 32
2022 Q3 36.9M $291M +$3.21M $7.76 24
2022 Q2 36.4M $190M +$182M $5.25 21
2022 Q1 654K $7.26M +$7.26M $11.10 1